Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Treating primary cicatricial alopecia is difficult and requires evidence-based methods.

In this study, researchers found that in the UK, laser treatment for hidradenitis suppurativa had the highest participant eligibility and preference compared to other interventions, highlighting its potential priority in future trials.

This article discusses the chronic inflammatory skin diseases acne keloidalis nuchae and dissecting cellulitis of the scalp, focusing on their shared etiology and differing progression, and reports no new clinical findings.

This observational study using NHANES data from 2011 to 2020 found that the use of hair, skin, and nails supplements almost doubled, particularly among younger, female, Black, and Hispanic/Latino individuals, despite limited evidence on their efficacy and potential health risks.

This systematic review discusses the treatment characteristics and outcomes for frontal fibrosing alopecia specifically in Black patients with skin of color, addressing a gap in clinical evidence due to underrepresentation in studies.

In this case series, four African American women with treatment-resistant central centrifugal cicatricial alopecia showed scalp itch relief and significant hair regrowth after using a new botanical formula for 8 weeks to 1 year, with no adverse effects reported.

This study found that using an LED array with an 863 nm wavelength delayed tumor development and reduced systemic inflammatory cytokines in DMBA/TPA-induced mouse skin tumors, suggesting potential but limited benefits of light therapy.

This review discusses treatment options for various types of alopecia in children and reports no new clinical results; it analyzes the existing literature on safety and efficacy.

This case study reports that tofacitinib effectively treated alopecia areata in a patient with Crohn's disease and maintained her Crohn's disease management.

In this study, 5-aminolevulinic acid photodynamic therapy did not improve hair growth in patients with androgenetic alopecia but was safe and slightly reduced scalp sebum secretion.

This article reviews therapeutic methods for managing non-cicatricial alopecia associated with various conditions and provides no new clinical results.

In this study, nondermal-derived CD34+ cells from adult peripheral blood were found to enhance wound healing and contribute to hair follicle neogenesis and skin regeneration.

This source reviews treatments for female pattern hair loss and discusses the challenges in achieving effective regrowth, highlighting the need for combinations of topical, systemic, and interventional therapies.

This overview describes the Dermatologic Surgery journal's full coverage of skin surgery topics, including various surgical procedures, but it reports no new research findings.

This case report describes a patient with alopecia universalis who experienced quick hair regrowth after being treated with alitretinoin.

This report describes an elderly woman whose nonclassic 11-hydroxylase deficiency, presenting as acne and male pattern alopecia, may have been ameliorated by Ashwagandha root in a dose-related manner.

This case report describes a non-mosaic Turner-Syndrome individual with global cerebral atrophy, significant cognitive impairment, and severe treatment-resistant schizophrenia.

This study found that topical minoxidil is effective for treating female pattern hair loss, regardless of age or androgen levels, while the efficacy of antiandrogens remains limited.

This review discusses treatments for female sexual dysfunction in postmenopausal women, noting that the effectiveness of current pharmaceutical options is inconclusive and emphasizing the importance of individualized care.

This editorial discusses the implications of neuroimaging for the treatment of epilepsy and reports no new clinical results; the author emphasizes its potential impact on therapeutic strategies.

This study found that pulsed diode laser treatment safely and effectively cleared lesions and reduced the appearance of dark plugs in trichostasis spinulosa for up to 20 weeks in dark-skinned individuals.

This review examines the differences in dermatology practices between Europe and North America, noting that European dermatologists often prioritize evaluating patients' psychosocial factors and utilize nondrug treatments, unlike their North American counterparts.

No treatment reliably changes Alopecia Areata's course; reassurance and possibly a wig are recommended.

This letter discusses concerns about the term "telogen effluvium" and suggests using "telogen defluxion" instead, but reports no new results.

This review explores the efficacy and safety of treatments for dissecting cellulitis of the scalp, revealing a predominance of case reports and series, and concludes that randomized controlled trials are needed for better evidence-based therapies.

This systematic review reported that habit reversal training showed the most consistent benefit for treating pediatric trichotillomania, while evidence for pharmacological treatments and alternative therapies like N-acetylcysteine remains insufficient, highlighting the need for early behavioral intervention and further research into standardized treatment protocols.

In this study, a retrospective analysis at Erasmus University Medical Center found that methotrexate and cyclosporine A may be most effective for lichen planopilaris and cyclosporine A and retinoids for frontal fibrosing alopecia, although side effects were a concern.

This systematic review identified that surgical treatments show a positive response for eyebrow and eyelash leukotrichia, while topical tofacitinib appears promising but requires further research to confirm its efficacy.

This case report by the researchers observed a complete remission of lichen planopilaris in a 58-year-old woman after treatment with the JAK-1 inhibitor abrocitinib, although they noted that concurrent topical therapy might have contributed to this outcome.

This study reviewed literature on patient preferences for severe alopecia areata treatment, finding diverse tolerance for risks like infections and cancer in exchange for effectiveness. Patients favored safe, convenient, and effective topical treatments and valued shared decision-making with healthcare providers.